60 likes | 246 Views
Common themes . TRIPS flexibilities Assertion and erosion of flexibilities Legal and regulatory reform Use of flexibilities: opposition has generated more success; CL less success Political will to issue CLs? Opportunities + threats EAC, EPO, Bangui reform etc. Common themes .
E N D
Common themes • TRIPS flexibilities • Assertion and erosion of flexibilities • Legal and regulatory reform • Use of flexibilities: opposition has generated more success; CL less success • Political will to issue CLs? • Opportunities + threats • EAC, EPO, Bangui reform etc
Common themes • Shifting political contexts • Financing: Global Fund Round 11 cancellation, shrinking national budgets • Brazil, China and Russia • FTAs • EU India • TPP • EU ASEAN • (Non EU countries FTAs)
Common themes • Indian generic industry mergers, tie ins, buy outs • “Next wave” of national threats • Training of judges • IP enforcement meetings [linkage to public health and safety/influence of NDRAs] • Regional IP meetings sponsored by WIPO • “Susan Finston” syndrome
Common themes • Local production: what is happening in our countries • Capacity building • Regulatory, price, quality • Voluntary licenses are taking the fight out of civil society • Civil society divisions • Defending middle income country markets for generic competition • De-toothing generic industry • Gives pharma rosy glow
Common themes • Powerful activism, treatment literacy are crucial to our success • We have diverse political, capacity, mobilization experiences • Need stronger links between movements including non health movements; regionally and globally • Access to information
Campaign strategies • Aggressive proactive national, regional and global campaign to: • Reform IP laws and policies • Expand tactical opposition efforts • What will it take? • Products and company; disease; FTA campaigns • Kaletra campaign • Novartis Supreme Court case • Revisiting links with antiglobalization, other ‘allied’ movements